174 related articles for article (PubMed ID: 37154966)
1. Impact of the first-line antiretroviral therapy on soluble markers of inflammation in cohort of human immunodeficiency virus type 1 in Moroccan patients: a prospective study.
Haddaji A; Ouladlahsen A; Lkhider M; Bensghir R; Jebbar S; Hilmi S; Abbadi I; Sodqi M; Marih L; Pineau P; El Filali KM; Ezzikouri S
Arch Microbiol; 2023 May; 205(6):223. PubMed ID: 37154966
[TBL] [Abstract][Full Text] [Related]
2. TNF-α levels in HIV-infected patients after long-term suppressive cART persist as high as in elderly, HIV-uninfected subjects.
De Pablo-Bernal RS; Ruiz-Mateos E; Rosado I; Dominguez-Molina B; Alvarez-Ríos AI; Carrillo-Vico A; De La Rosa R; Delgado J; Muñoz-Fernández MA; Leal M; Ferrando-Martínez S
J Antimicrob Chemother; 2014 Nov; 69(11):3041-6. PubMed ID: 25011654
[TBL] [Abstract][Full Text] [Related]
3. Comparative impact of antiretroviral drugs on markers of inflammation and immune activation during the first two years of effective therapy for HIV-1 infection: an observational study.
Hattab S; Guihot A; Guiguet M; Fourati S; Carcelain G; Caby F; Marcelin AG; Autran B; Costagliola D; Katlama C
BMC Infect Dis; 2014 Mar; 14():122. PubMed ID: 24589015
[TBL] [Abstract][Full Text] [Related]
4. Circulating biomarker correlates of left atrial size and myocardial extracellular volume fraction among persons living with and without HIV.
Peterson TE; Landon C; Haberlen SA; Bhondoekhan F; Plankey MW; Palella FJ; Piggott DA; Margolick JB; Brown TT; Post WS; Wu KC
BMC Cardiovasc Disord; 2022 Sep; 22(1):393. PubMed ID: 36057773
[TBL] [Abstract][Full Text] [Related]
5. Soluble biomarkers of immune activation and inflammation in HIV infection: impact of 2 years of effective first-line combination antiretroviral therapy.
Hattab S; Guiguet M; Carcelain G; Fourati S; Guihot A; Autran B; Caby F; Marcelin AG; Costagliola D; Katlama C
HIV Med; 2015 Oct; 16(9):553-62. PubMed ID: 25944318
[TBL] [Abstract][Full Text] [Related]
6. Asymptomatic HIV People Present Different Profiles of sCD14, sRAGE, DNA Damage, and Vitamins, according to the Use of cART and CD4
Tasca KI; Correa CR; Caleffi JT; Mendes MB; Gatto M; Manfio VM; de Camargo CC; Tavares FC; Biasin M; de Souza LDR
J Immunol Res; 2018; 2018():7531718. PubMed ID: 29992171
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-37 Expression Is Increased in Chronic HIV-1-Infected Individuals and Is Associated with Inflammation and the Size of the Total Viral Reservoir.
Højen JF; Rasmussen TA; Andersen KL; Winckelmann AA; Laursen RR; Gunst JD; Møller HJ; Fujita M; Østergaard L; Søgaard OS; Dinarello CA; Tolstrup M
Mol Med; 2015 Apr; 21(1):337-45. PubMed ID: 25879630
[TBL] [Abstract][Full Text] [Related]
8. Monocyte count and soluble markers of monocyte activation in people living with HIV and uninfected controls.
Knudsen AD; Bouazzi R; Afzal S; Gelpi M; Benfield T; Høgh J; Thomsen MT; Trøseid M; Nordestgaard BG; Nielsen SD
BMC Infect Dis; 2022 May; 22(1):451. PubMed ID: 35546661
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Integrase Strand Transfer Inhibitors (INSTIs) and Protease-Boosted Inhibitors (PIs) on the Reduction in Chronic Immune Activation in a Virally Suppressed, Mainly Male Population Living with HIV (PLWH).
Nitsotolis T; Kyriakoulis KG; Kollias A; Papalexandrou A; Kalampoka H; Mastrogianni E; Basoulis D; Psichogiou M
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399618
[No Abstract] [Full Text] [Related]
10. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
11. A plasma biomarker signature of immune activation in HIV patients on antiretroviral therapy.
Kamat A; Misra V; Cassol E; Ancuta P; Yan Z; Li C; Morgello S; Gabuzda D
PLoS One; 2012; 7(2):e30881. PubMed ID: 22363505
[TBL] [Abstract][Full Text] [Related]
12. Monocyte activation markers in cerebrospinal fluid associated with impaired neurocognitive testing in advanced HIV infection.
Kamat A; Lyons JL; Misra V; Uno H; Morgello S; Singer EJ; Gabuzda D
J Acquir Immune Defic Syndr; 2012 Jul; 60(3):234-43. PubMed ID: 22569268
[TBL] [Abstract][Full Text] [Related]
13. The effect of HAART-induced HIV suppression on circulating markers of inflammation and immune activation.
Wada NI; Jacobson LP; Margolick JB; Breen EC; Macatangay B; Penugonda S; Martínez-Maza O; Bream JH
AIDS; 2015 Feb; 29(4):463-71. PubMed ID: 25630041
[TBL] [Abstract][Full Text] [Related]
14. Selected inflammatory and coagulation biomarkers pre-viral suppression in people with human immunodeficiency virus (HIV) infection without overt cardiovascular disease: Is there a need to redefine reference indices?
Louw S; Mayne ES; Jacobson BF; Mayne AL
Cytokine; 2023 May; 165():156174. PubMed ID: 36996538
[TBL] [Abstract][Full Text] [Related]
15. Intestinal microbiota, microbial translocation, and systemic inflammation in chronic HIV infection.
Dinh DM; Volpe GE; Duffalo C; Bhalchandra S; Tai AK; Kane AV; Wanke CA; Ward HD
J Infect Dis; 2015 Jan; 211(1):19-27. PubMed ID: 25057045
[TBL] [Abstract][Full Text] [Related]
16. No evidence of a synergistic effect of HIV infection and diabetes mellitus type 2 on fat distribution, plasma adiponectin or inflammatory markers.
Hove-Skovsgaard M; Abildgaard J; Gelpi M; Gaardbo JC; Kolte L; Ullum H; Trøseid M; Lindegaard B; Nielsen SD
BMC Infect Dis; 2020 Nov; 20(1):882. PubMed ID: 33238950
[TBL] [Abstract][Full Text] [Related]
17. Brief Report: Systemic Inflammation, Immune Activation, and Impaired Lung Function Among People Living With HIV in Rural Uganda.
North CM; Muyanja D; Kakuhikire B; Tsai AC; Tracy RP; Hunt PW; Kwon DS; Christiani DC; Okello S; Siedner MJ
J Acquir Immune Defic Syndr; 2018 Aug; 78(5):543-548. PubMed ID: 29683991
[TBL] [Abstract][Full Text] [Related]
18. The impact of integrase inhibitor-based regimens on markers of inflammation among HIV naïve patients.
Quiros-Roldan E; Castelli F; Bonito A; Vezzoli M; Calza S; Biasiotto G; Zanella I;
Cytokine; 2020 Feb; 126():154884. PubMed ID: 31670006
[TBL] [Abstract][Full Text] [Related]
19. Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.
Sereti I; Krebs SJ; Phanuphak N; Fletcher JL; Slike B; Pinyakorn S; O'Connell RJ; Rupert A; Chomont N; Valcour V; Kim JH; Robb ML; Michael NL; Douek DC; Ananworanich J; Utay NS;
Clin Infect Dis; 2017 Jan; 64(2):124-131. PubMed ID: 27737952
[TBL] [Abstract][Full Text] [Related]
20. HIV and Obesity Comorbidity Increase Interleukin 6 but Not Soluble CD14 or D-Dimer.
Taylor BS; So-Armah K; Tate JP; Marconi VC; Koethe JR; Bedimo RJ; Butt AA; Gibert CL; Goetz MB; Rodriguez-Barradas MC; Womack JA; Gerschenson M; Lo Re V; Rimland D; Yin MT; Leaf D; Tracy RP; Justice AC; Freiberg MS
J Acquir Immune Defic Syndr; 2017 Aug; 75(5):500-508. PubMed ID: 28696344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
